N/A N=25 FMBI With War-affected Families
Family Mindfulness-based Intervention in War-affected Families · Intergenerational Trauma · War-Related Trauma
Primary: Youth Adjustment — -2.3 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=33 Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab
Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis
Primary: Change in Cell Mediated Immunity — 33; 33; 33; 50 cells per million — p=0.16
N/A N=35 Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy
COPD Exacerbation
Primary: Change in Exhaled Breath Metabolites — 3298 breath metabolites
Phase 3 N=24 Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes
Diabetes Mellitus, Type 2
Primary: Glygocalyx Integrity - Perfused Boundary Region — 0.11; -0.16 Delta micrometers (mcm)
N/A N=202 The DETOUR 2 Clinical Trial
Peripheral Arterial Disease
Primary: Primary Patency — 72.3 Percentage of Participants
Phase 1 N=141 A PK Study Comparing MB05, EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers.
Healthy Volunteers
Primary: Comparison of the Pharmacokinetic (PK) Profiles Between MB05 and EU-Synagis®, Between MB05 and US-Synagis® and Between EU-Synagis® and US-Synagis® in Terms of Area Under…
N/A N=48 A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication
Drug Abuse
Primary: Use of Self-administered Pupillometry Using a Mobile Phone Application Can be Used to Collect Pupillograms Before and Under the Influence of Phenethylamines…
N/A N=46 Activity, Adiposity, and Appetite in Adolescents 2
Obesity · Metabolic Disease · Insulin Sensitivity
Primary: Appetite- Subjective — 9239.4; 7879.6; 6130.5; 8970.0 score on a scale*min
Phase 3 N=555 Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
Seasonal Allergic Rhinitis · Rhinoconjunctivitis
Primary: Combined Symptom and Medication Score (CSMS) Averaged Over the Peak Grass Pollen Season (GPS) — 1.08; 1.34 score on a scale — p=0.00048
N/A N=22 Measuring Fatty Acid Oxidation in Cerebral Metastases Using [18F]FPIA
Cerebral Metastases
Primary: Quantitative Measurement of [18F]FPIA Uptake Within the Cerebral Metastases of Treatment naïve Patients. — 1.54; 1.47; 1.48 SUV_max (kBq/L/kBq/g)
N/A N=26 Mechanistic Inflammatory Sub-study Embedded Within the Albumin vs Balanced Crystalloid Trial
Sepsis
Primary: Longitudinal Change Over Time in Cell Types and Pro and Anti Inflammatory Cytokines in Sepsis. — 14; 12 participants
Phase 3 N=447 To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
Glaucoma, Open-Angle · Ocular Hypertension
Primary: Mean Change in Intra-ocular Pressure — -5.30; -5.16; -6.92; -6.57 mmHG
Phase 2 N=25 A Study of E6011 in Participants With Active Crohn's Disease
Crohn's Disease
Primary: Percentage of Participants With Clinical Response (CR) 100 (CR100) at Week 12 — 33.3; 23.1 percentage of participants
Phase 2 N=216 A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)
Cancer
Primary: Dose Limiting Toxicities (DLT) in the Trial Subjects. — 0; 0; 0; 0 DLT
Phase 2 N=288 L9LS MAb in Malian Adults
Plasmodium Falciparum Infection · Malaria
Primary: Number of Participants With Local Adverse Events (AEs) — 7; 1; 0; 0 Participants